SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-005368
Filing Date
2022-04-13
Accepted
2022-04-13 16:00:25
Documents
6
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220525xdef14a.htm DEF 14A 1750827
2 GRAPHIC tmb-20220525xdef14a003.jpg GRAPHIC 15358
3 GRAPHIC tmb-20220525xdef14a012.jpg GRAPHIC 45527
4 GRAPHIC tmb-20220525xdef14a004.jpg GRAPHIC 5154
5 GRAPHIC tmb-20220525xdef14a025.jpg GRAPHIC 159441
6 GRAPHIC tmb-20220525xdef14a026.jpg GRAPHIC 130779
  Complete submission text file 0001558370-22-005368.txt   2243242
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Filer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37478 | Film No.: 22824698
SIC: 8071 Services-Medical Laboratories